General Information of Drug (ID: DM6IN4U)

Drug Name
PfSPZ-Cvac
Indication
Disease Entry ICD 11 Status REF
Malaria 1F40-1F45 Phase 2 [1]
Cross-matching ID
TTD ID
D0TY1Y

References

1 ClinicalTrials.gov (NCT03503058) Safety, Tolerability, Immunogenicity and Protective Efficacy of PfSPZ Vaccine and PfSPZ-CVac in Indonesian Adults Against Naturally-Transmitted Malaria. U.S. National Institutes of Health.